Woodline Partners’s Seelos Therapeutics, Inc. Common Stock SEEL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-189
| Closed | -$133K | – | 692 |
|
|
2023
Q3 | $133K | Buy |
189
+40
| +27% | +$28.2K | ﹤0.01% | 566 |
|
|
2023
Q2 | $686K | Buy |
+149
| New | +$686K | 0.01% | 513 |
|
|
2022
Q4 | – | Sell |
-182
| Closed | -$720K | – | 870 |
|
|
2022
Q3 | $720K | Sell |
182
-120
| -40% | -$475K | 0.01% | 558 |
|
|
2022
Q2 | $788K | Sell |
302
-428
| -59% | -$1.12M | 0.01% | 536 |
|
|
2022
Q1 | $2.35M | Sell |
730
-324
| -31% | -$1.04M | 0.04% | 361 |
|
|
2021
Q4 | $6.6M | Sell |
1,054
-86
| -8% | -$538K | 0.09% | 251 |
|
|
2021
Q3 | $10.6M | Buy |
1,140
+347
| +44% | +$3.21M | 0.17% | 153 |
|
|
2021
Q2 | $8.04M | Buy |
793
+608
| +329% | +$6.16M | 0.15% | 161 |
|
|
2021
Q1 | $3.55M | Buy |
+185
| New | +$3.55M | 0.08% | 225 |
|